Abstract Details

Title Suppression of Experimental Autoimmune Myasthenia Gravis by Interferon-gamma-Modified Dendritic Cells Is Mediated through Induction of Indoleamine 2,3-Dioxygenase

Topic

Presentation(s)

Poster/Presentation
Number 106

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael A. Johnson, MD, FAAN (Colorado Neurodiagnostics)	Dr. Johnson has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for CEFALY technologies.
	No disclosure on file
Darshan Pandya, MD	Dr. Pandya has nothing to disclose.